Joe’s Top 7 Articles from the Week of October 10th

I review almost two dozen journals every week so you don’t have to! Every Monday I will provide a members-only curated digest of new critical care pharmacy literature.  This week’s 7 articles cover:

1. Ceftazidime-avibactam had less AKI than combo therapy but resistance did develop

2.  A review of the physiology of early goal-directed therapy & reconciliation of disparate trial results

3. Levosimendan is a flop 🙁

4. High vs low risk doesn’t work for candidiasis, but high vs intermediate vs low risk does

5. A review of opioid-induced hallucination

6. Disseminated intravascular coagulation in septic patients can be predicted early

7.  Carbapenem exposure quadrupled the hazards of acquiring A. baumannii even after controlling for severity of illness

If you are a founding Beta Program member please log in here:

Username or Email Address

Password

Remember Me

Or

Connect With

Lost Password? Click here to have it emailed to you.